Erzin, G. Et Al. 2019. Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.29, no.4 , 394-398.

Erzin, G., Topcuoglu, C., Bayram, S., Karadag, H., ÖZKAYA, G., Turhan, T., ... Goka, E.(2019). Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.29, no.4, 394-398.

Erzin, Gamze Et Al. "Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity," PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.29, no.4, 394-398, 2019

Erzin, Gamze Et Al. "Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity." PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.29, no.4, pp.394-398, 2019

Erzin, G. Et Al. (2019) . "Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity." PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.29, no.4, pp.394-398.

@article{article, author={Gamze Erzin Et Al. }, title={Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity}, journal={PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY}, year=2019, pages={394-398} }